Ve Bionic Etf (CYBG)
LSE
News
Market Data
Register to chat with like-minded investors on our interactive forums.
The current CYBG market cap is 20.67B. The company's latest EPS is GBP 0.1829 and P/E is 84.58.
| Year End September 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Total Revenue | 1.75B | 1.45B | 1.49B | 1.72B | 1.83B |
| Operating Income | 1.5B | 943M | 1.63B | 1.67B | 1.52B |
| Net Income | -212M | -141M | 474M | 537M | 246M |
| Year End September 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Total Assets | 91B | 90.26B | 89.1B | 91.91B | 91.79B |
| Total Liabilities | 85.98B | 85.33B | 83.63B | 85.57B | 86.18B |
| Total Equity | 5.02B | 4.93B | 5.47B | 6.34B | 5.61B |
| Year End September 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Operating | N/A | N/A | N/A | N/A | N/A |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | N/A | N/A | N/A | N/A | N/A |
| Market Cap | 20.67B |
| Price to Earnings Ratio | 84.58 |
| Price to Sales Ratio | 11.39 |
| Price to Cash Ratio | 1.74 |
| Price to Book Ratio | 3.71 |
| Dividend Yield | - |
| Shares Outstanding | 1.34B |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.17 (1.12%) |
| Company Name | Ve Bionic Etf |
| Address |
jubilee house newcastle upon tyne NE3 4PL |
| Website | https://www.cybg.com |
| Industry | commercial banks, nec (6029) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
